| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/26/2015 | US20150056157 Vascular delivery systems |
| 02/26/2015 | US20150056147 Abuse-proofed dosage form |
| 02/26/2015 | US20150056145 Magnetic nanoparticle-samirna complex and method for preparing same |
| 02/26/2015 | US20150056144 Encapsulated diagnostics and therapeutics in nanoparticles - conjugated to tropic cells and methods for their use |
| 02/26/2015 | US20150056143 Light-guiding hydrogel devices for cell-based sensing and therapy |
| 02/26/2015 | US20150056140 Electrolyte purgatives |
| 02/26/2015 | US20150056139 Telodendrimers and nanocarriers and methods of using same |
| 02/25/2015 | EP2839860A1 Pyrrolobenzodiazepines and conjugates thereof |
| 02/25/2015 | EP2839835A1 Encapsulated formulation |
| 02/25/2015 | EP2839829A1 Sustained release tablet containing levodropropizine and method for preparing same |
| 02/25/2015 | EP2839015A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids |
| 02/25/2015 | EP2838566A2 Optimised subcutaneous therapeutic agents |
| 02/25/2015 | EP2838565A1 Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient |
| 02/25/2015 | EP2838564A1 Highly branched alpha-d-glucans |
| 02/25/2015 | EP2838563A1 Compositions and methods comprising energy absorbing materials for follicular delivery |
| 02/25/2015 | EP2838550A1 Polymeric conjugates of c1-inhibitors |
| 02/25/2015 | EP2838525A1 Fatty acid derivative-polymer conjugate |
| 02/25/2015 | EP2838524A1 Compositions for topical treatment of microbial infections |
| 02/25/2015 | EP2838512A1 Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
| 02/25/2015 | EP2838509A1 Formulations and methods for treatment of inflammatory skin diseases |
| 02/25/2015 | EP2838508A1 Formulations and methods for treatment of acne and inflammatory skin conditions |
| 02/25/2015 | EP2838506A1 Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
| 02/24/2015 | US8962804 Meditopes and meditope-binding antibodies and uses thereof |
| 02/24/2015 | US8962799 Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| 02/24/2015 | US8962793 ErbB interface peptidomimetics and methods of use thereof |
| 02/24/2015 | US8962699 Liquid composition to be filled in soft capsules |
| 02/24/2015 | US8962698 Rebaudioside-mogroside V blends |
| 02/24/2015 | US8962697 Bioreponsive polymers |
| 02/24/2015 | US8962696 Microemulsion preparation of high concentration propofol for anesthetic uses |
| 02/24/2015 | US8962686 Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| 02/24/2015 | US8962673 Use of melatonin for treating and/or preventing mucositis |
| 02/24/2015 | US8962669 Antimycotic pharmaceutical composition |
| 02/24/2015 | US8962647 Conjugate of polyethylene gylcol and naloxone and pharmaceutical composition and use thereof |
| 02/24/2015 | US8962601 Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids |
| 02/24/2015 | US8962595 Compositions of small molecule therapeutics |
| 02/24/2015 | US8962577 Controlled release formulations for the delivery of HIF-1 inhibitors |
| 02/24/2015 | US8962573 Compounds targeting the cation-independent mannose 6-phosphate receptor |
| 02/24/2015 | US8962566 Multi-arm polymeric alkanoate conjugates |
| 02/24/2015 | US8962552 Nanoparticles of therapeutic agents having low water solubility |
| 02/24/2015 | US8962549 Polymeric benzyl carbonate-derivatives |
| 02/24/2015 | US8962548 Multi-component biological transport systems |
| 02/24/2015 | US8962547 Compositions comprising enzyme-cleavable oxycodone prodrug |
| 02/24/2015 | US8962316 Choroid plexus device |
| 02/24/2015 | US8962064 Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
| 02/24/2015 | US8962040 Vaporized medicants and methods of use |
| 02/24/2015 | US8962036 Disintegrable formulations of lanthanum carbonate |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | US8962030 Nanoparticles for delivery of active agents |
| 02/24/2015 | US8962029 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/24/2015 | US8962028 Topical steroid composition and method |
| 02/24/2015 | US8962025 Rapidly acting dry sealant and methods for use and manufacture |
| 02/24/2015 | US8962023 UV cured gel and method of making |
| 02/24/2015 | US8962017 Formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
| 02/24/2015 | US8962012 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same |
| 02/24/2015 | US8962008 Hybrid polymeric materials for medical applications and preparation thereof |
| 02/24/2015 | US8962005 Gastric reflux resistant dosage forms |
| 02/24/2015 | US8962002 Alloplastic injectable dermal filler and methods of use thereof |
| 02/24/2015 | US8961988 Compositions and methods for the treatment or prevention of hepatitis B virus infection |
| 02/24/2015 | US8961983 Mucosal vaccine using cationic nanogel |
| 02/24/2015 | US8961981 Targeting the neuromuscular junction for treatment |
| 02/24/2015 | US8961980 Monoclonal antibodies for treatment of cancer |
| 02/24/2015 | US8961964 High concentration antibody and protein formulations |
| 02/24/2015 | US8961957 Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10 |
| 02/24/2015 | US8961949 Polymer-metal complex composite having MRI contrast ability and MRI contrasting and/or antitumor composition using the same |
| 02/24/2015 | US8961943 O/W-emulsifiers, O/W-emulsions and methods of manufacture thereof |
| 02/24/2015 | US8961592 Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functional-ized RGD peptidomimetics |
| 02/24/2015 | US8961501 Method for applying flowable hydrogels to a cornea |
| 02/24/2015 | US8960128 Topical anesthetic composition |
| 02/24/2015 | CA2791165C A conjugate comprising cholesterol linked to tetracycline |
| 02/24/2015 | CA2777682C Dendrimer compositions and methods of synthesis |
| 02/24/2015 | CA2771403C Quinoline derivative-containing pharmaceutical composition |
| 02/24/2015 | CA2631491C Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 02/24/2015 | CA2616508C Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 02/24/2015 | CA2507522C Oral drug delivery system |
| 02/24/2015 | CA2489467C Humanized monoclonal antibody hpam4 |
| 02/24/2015 | CA2447695C Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 02/19/2015 | WO2015023979A1 Discrete peg constructs |
| 02/19/2015 | WO2015023941A1 Oligonucleotides targeting euchromatin regions of genes |
| 02/19/2015 | WO2015023889A1 Rapidly-dissolving thin film formulation of water soluble digitalis glycoside for the treatment of congestive heart disease |
| 02/19/2015 | WO2015023775A1 A novel plga-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery |
| 02/19/2015 | WO2015023355A1 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment |
| 02/19/2015 | WO2015023244A1 Drug with cerebro-protective effect |
| 02/19/2015 | WO2015022944A1 Method for reducing surface free energy and composition having reduced surface free energy |
| 02/19/2015 | WO2015022484A1 Matrix gel |
| 02/19/2015 | WO2015022454A1 Novel self-emulsifying instant solid system made from cyclodextrins and oil(s) for oral administration |
| 02/19/2015 | WO2015022400A1 Glp-1 derivatives, and uses thereof |
| 02/19/2015 | WO2015022348A1 Preparation for protection against extrinsic and intrinsic skin aging |
| 02/19/2015 | WO2015021993A1 Pharmacologically active modified sb101 molecules and uses thereof |
| 02/19/2015 | WO2015021711A1 Improved fusion protein of human blood coagulation factor fvii-fc, preparation method therefor and use thereof |
| 02/19/2015 | WO2015021534A1 Compositions and methods for control of marine ectoparasites |
| 02/19/2015 | WO2014194429A9 Targeted enzyme compounds and uses thereof |
| 02/19/2015 | WO2014190440A9 Abuse deterrent immediate release formulation |
| 02/19/2015 | US20150051559 Transdermal patch for treatment of dementia or alzheimer type dementia |
| 02/19/2015 | US20150051392 Functionalisation of cage amine ligands for metallo-radiopharmaceuticals |
| 02/19/2015 | US20150051382 Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndrome while avoiding a rebound |
| 02/19/2015 | US20150051380 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 02/19/2015 | US20150051371 Carbohydrate-based drug delivery polymers and conjugates thereof |
| 02/19/2015 | US20150051347 Block copolymer having phenylboronic acid group introduced therein, and use thereof |
| 02/19/2015 | US20150051300 Antiinfective free intramammary veterinary composition |
| 02/19/2015 | US20150051298 Methods for producing optimal stable nanoemulsions and formulations obtained therefrom |